U.S. Oil and Gas Stock News

Northrop Grumman stock has delivered a 62.4% gain over the past five years, yet current valuation checks and intrinsic value estimates both point to the shares trading below what the underlying cash flows imply. With market sentiment still digesting mixed shorter term returns, the question is whether the current price fully reflects the company’s long term contract and earnings profile. Over five years, Northrop Grumman has returned 62.4%, which suggests long term holders have been rewarded...

Recent analyst commentary compared Ormat Technologies with Ameresco, highlighting Ormat’s Zacks Rank of #3 (Hold) and relatively less attractive valuation metrics, alongside expectations, since realized in the past, that its upcoming quarterly report would show higher revenue but lower year-over-year earnings. Analysts had also revised Ormat’s earnings estimates upward and pointed to a high Earnings ESP and a history of topping EPS expectations, which together drew fresh attention to how...

Investors watching the latest Goldman Sachs tribunal decision on sex discrimination and unfair dismissal can see how quickly employment disputes turn into real financial and reputational costs. Human resources and employment law services sit close to this pressure point, from compliance advice to managing workplace disputes. When a £1.45mn award and critical findings on dismissal processes hit headlines, that can influence how companies think about risk management and where they spend on...

AppLovin (APP) is back in focus after fresh analyst commentary highlighted expectations for quarterly results above the company’s guidance, with particular attention on the gaming segment and sequential revenue trends. See our latest analysis for AppLovin. Recent excitement around AppLovin’s expected results sits against a weaker near term trend, with the share price down 19.91% over 30 days and 35.40% year to date. However, a 3 year total shareholder return above 10x still points to strong...

Sirius XM Holdings Inc. recently announced SiriusXM Sports Pass, a sports-focused subscription launched on September 1, 2026, offering comprehensive live game coverage, local sports talk, exclusive sports channels, and podcasts for US$5 per month or US$49 per year, alongside its existing plans. This move packages SiriusXM’s extensive sports rights and new local station additions like WFAN and ESPN LA 710 into a low-priced, sports-only tier that could shift how fans engage with its ecosystem...

Why Stanley Black & Decker Stock Is Back in Focus After Q2 Earnings Stanley Black & Decker (SWK) moved back onto investors’ radar after second quarter results showed net income of $351.3 million and higher earnings per share, alongside a raised 2026 GAAP EPS outlook. See our latest analysis for Stanley Black & Decker. After these Q2 results and the raised 2026 GAAP EPS outlook, Stanley Black & Decker’s share price at US$93.05 sits on a year to date share price return of 21.68%. The 1 year...

Gartner stock has had a tough run over the past year, yet current valuation checks suggest the share price may now sit below what its Discounted Cash Flow (DCF) and earnings multiple signals imply for intrinsic value. Over the past 12 months the share price has fallen 51.8%, which puts recent gains into context and raises the question of whether sentiment has moved further than the fundamentals. Recent headlines around Gartner's AI forecasts and its role in shaping spending on AI...

Nexstar Media Group (NXST) is drawing attention after announcing that its Kansas stations will air a live, multi market telecast of the Democratic governor candidates' debate on July 31 across TV and digital platforms. See our latest analysis for Nexstar Media Group. The debate announcement comes as Nexstar Media Group’s recent momentum has picked up, with a 7 day share price return of 8.71% and a 30 day share price return of 10.27%, even though the year to date share price return is down...

Cloud giants are back in focus after Meta’s steep share price drop, Microsoft’s upbeat data centre message, Qualcomm’s weak smartphone update, and Arm’s mixed market reaction. At the same time, US borrowing costs are sitting at a 19 year high as the Federal Reserve holds rates steady. For investors, the spotlight is now on companies that build and power the digital plumbing behind all that computing. This article reveals 3 stocks from a data centre infrastructure and energy screener that are...

In the lead-up to its latest quarterly report, Monolithic Power Systems drew attention as Wall Street analysts projected earnings of US$5.88 per share and revenue of US$903.97 million, both pointing to very large year-over-year percentage increases. An interesting wrinkle is that, even with these strong expectations, the consensus earnings estimate was trimmed slightly in the last month, hinting at some caution around just how strong the upcoming results might be. Next, we’ll examine how...

Viatris Inc. recently received U.S. Food and Drug Administration approval for Gwyn Lo, a once-weekly low-estrogen combined hormonal contraceptive patch for women with a body mass index below 30 kg/m², supported by Phase 3 data showing contraceptive efficacy, a well-characterized safety profile and strong patch adhesion. By adding a low-dose, non-invasive, weekly contraceptive option that targets women seeking convenience and reversibility, Viatris is broadening its branded and complex...

International Paper has delivered a 33.3% gain over the past three years, yet the stock still screens as undervalued on key valuation checks, which puts the recent price moves and containerboard news in sharp focus for investors. A 33.3% return over three years suggests International Paper has already rewarded patient shareholders. The question is whether the current price still leaves room for further upside or now embeds much of that progress. Recent containerboard price increase plans and...

Investors are watching Tarsus Pharmaceuticals (TARS) ahead of its upcoming quarterly report, with expectations for a loss alongside higher revenue compared with last year and a cautious Zacks Rank of #4. See our latest analysis for Tarsus Pharmaceuticals. At a share price of US$58.52, Tarsus Pharmaceuticals has seen its share price decline 27.6% year to date, even though the 1 year total shareholder return is 46.3%. This suggests long term holders are still sitting on strong gains despite...

On 28 July 2026, Schwarz Digits and Zscaler announced a partnership to run the Zscaler Zero Trust Exchange on Schwarz Digits’ STACKIT sovereign cloud, creating a Zero Trust SASE service hosted in German data centers for sectors such as public administration, defense, financial services, and healthcare. This collaboration directly targets European data sovereignty and AI-driven cyber risk concerns by offering a cloud-delivered security platform that is operated locally and aligned with...

Aon plc has already reported second-quarter 2026 results, with sales rising to US$4,246 million from US$4,155 million a year earlier, while quarterly net income and EPS from continuing operations eased slightly even as first-half revenue and earnings increased versus the prior year. The company continued its long-running buyback, repurchasing 1,700,000 shares for US$600 million in the quarter and bringing total repurchases under the program announced in 2012 to US$27.28 billion, while also...

Consumer lending stocks are feeling the strain as the Federal Reserve holds rates steady and energy driven inflation keeps household budgets tight. With borrowing costs elevated and credit cards, auto loans, and mortgages all putting pressure on consumers, some companies exposed to this news are facing tougher conditions than others. This article focuses on three consumer lending stocks that appear more vulnerable to the current rate and inflation backdrop. Each section explains how the...

Why Teleflex Stock Is Back in Focus After EZPLAZ FDA Approval Teleflex (TFX) is drawing fresh attention after the U.S. Food and Drug Administration approved EZPLAZ Freeze Dried Plasma, the first FDA licensed freeze dried plasma product for urgent bleeding situations. The approval gives Teleflex its first biologics license for a blood component and introduces a plasma option designed for environments where traditional frozen products are hard to store or prepare, including battlefield and...

Earlier this week, n-Lorem Foundation announced an early-stage research collaboration and exclusive global licence agreement with BioMarin Pharmaceutical to develop an investigational antisense oligonucleotide therapy for ReNU syndrome, with preclinical work underway and plans for future clinical studies. A key aspect of the deal is BioMarin’s intention to develop the medicine for broader use across the ReNU syndrome community, aiming to address an estimated 75% of cases and potentially...

FactSet Research Systems (FDS) is back in focus after expanding its relationship with RepRisk AG, which becomes a preferred partner for sustainable investing and business conduct risk data across FactSet client workflows. See our latest analysis for FactSet Research Systems. The latest RepRisk partnership news comes after a strong recent rebound in FactSet Research Systems’ share price, with a 7 day share price return of 15.02% and a 90 day share price return of 23.93%, even though the 1 year...

Capital Clean Energy Carriers (CCEC) stock is in focus after the company reported second quarter 2026 earnings, which showed higher sales alongside slightly lower net income and earnings per share compared with the same period last year. See our latest analysis for Capital Clean Energy Carriers. At a share price of $22.72, Capital Clean Energy Carriers has logged an 8.86% 1 month share price return and an 11.32% year to date share price return. Its 1 year total shareholder return is broadly...

In July 2026, First BanCorp. reported second-quarter 2026 results showing higher net interest income of US$229.13 million and net income of US$96.15 million year-on-year, alongside lower net charge-offs of US$15.98 million, completion of a US$112.78 million share repurchase program, and affirmation of a US$0.20 quarterly dividend. Together, stronger earnings, reduced credit losses, ongoing dividends, and completed buybacks highlight how First BanCorp. is actively returning capital while...

Why CVS Health Stock Is Back On Investors’ Radar CVS Health (CVS) has drawn fresh attention ahead of its upcoming quarterly earnings report, as investors weigh upbeat expectations alongside a run of recent business updates and industry recognition. Over the past year, CVS Health stock has outperformed the broader market and delivered a total return of 75.4%. The share price closed at US$105.92 on 29 July 2026, with gains of 2.3% over the past month and 27.2% over the past 3 months. See our...

Comfort Systems USA has delivered a very large 5 year share price return, yet current valuation checks and an intrinsic value estimate still point to the stock trading below what the business may be worth. That mix of a long run-up and an apparent discount is what many investors are now trying to make sense of. Comfort Systems USA shares are up about 20x over 5 years, which puts recent weakness in a much longer context of very strong gains for early holders. Record revenue and backlog can...

T1 Energy Inc. recently issued preliminary second-quarter 2026 guidance, projecting total net sales of about US$245 million to US$255 million on roughly 835 MW of module shipments, alongside a net loss from continuing operations of about US$34.0 million to US$37.0 million. The company also acquired advanced TOPCon solar intellectual property from Evervolt and closed its purchase of KORE Power, moves that remove future solar royalty costs and extend T1’s reach into energy storage and AI data...